Yonsei University

This study tests whether lecanemab, an FDA-approved Alzheimer's drug, can clear amyloid plaques in the brains of people with Parkinson's disease who also have early Alzheimer's pathology. About 60 adults aged 50-90 with mild cognitive impairment or early dementia will receive lec…

This study is for people with advanced biliary tract cancer whose disease is under control after initial chemotherapy and immunotherapy. It tests whether adding different drugs (lenvatinib, venadaparib, or IL-2) to ongoing immunotherapy can keep the cancer from growing longer tha…